1,2-Dichloroethane → Di-tert-butyl 2-(((R)-3-(4-(N-(4-(4-((R)-(4'-chlorobiphenyl-2-yl)(hydroxy)methyl)piperidin-1-yl)benzoyl)sulfamoyl)-2-(trifluoromethylsulfonyl)phenylamino)-4-(phenylthio)butyl)(ethyl)amino)ethyl phosphate

HRID 1771189ノート

反応式

HRID 1771189 の反応式
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=2[C@H:14]([OH:30])[CH:15]2[CH2:20][CH2:19][N:18]([C:21]3[CH:29]=[CH:28][C:24]([C:25](O)=[O:26])=[CH:23][CH:22]=3)[CH2:17][CH2:16]2)=[CH:4][CH:3]=1.C(Cl)CCl.C(N(CC)CC)C.[P:42]([O:54][CH2:55][CH2:56][N:57]([CH2:87][CH3:88])[CH2:58][CH2:59][C@@H:60]([NH:69][C:70]1[CH:75]=[CH:74][C:73]([S:76](=[O:79])(=[O:78])[NH2:77])=[CH:72][C:71]=1[S:80]([C:83]([F:86])([F:85])[F:84])(=[O:82])=[O:81])[CH2:61][S:62][C:63]1[CH:68]=[CH:67][CH:66]=[CH:65][CH:64]=1)([O:49][C:50]([CH3:53])([CH3:52])[CH3:51])([O:44][C:45]([CH3:48])([CH3:47])[CH3:46])=[O:43]>CN(C1C=CN=CC=1)C.C(Cl)Cl>[P:42]([O:54][CH2:55][CH2:56][N:57]([CH2:58][CH2:59][C@@H:60]([NH:69][C:70]1[CH:75]=[CH:74][C:73]([S:76](=[O:79])(=[O:78])[NH:77][C:25](=[O:26])[C:24]2[CH:28]=[CH:29][C:21]([N:18]3[CH2:19][CH2:20][CH:15]([C@H:14]([C:9]4[CH:10]=[CH:11][CH:12]=[CH:13][C:8]=4[C:5]4[CH:4]=[CH:3][C:2]([Cl:1])=[CH:7][CH:6]=4)[OH:30])[CH2:16][CH2:17]3)=[CH:22][CH:23]=2)=[CH:72][C:71]=1[S:80]([C:83]([F:85])([F:86])[F:84])(=[O:82])=[O:81])[CH2:61][S:62][C:63]1[CH:68]=[CH:67][CH:66]=[CH:65][CH:64]=1)[CH2:87][CH3:88])([O:44][C:45]([CH3:46])([CH3:48])[CH3:47])([O:49][C:50]([CH3:53])([CH3:52])[CH3:51])=[O:43]

参加物

7

反応物 4

HCID 111,2-DichloroethaneHCID 8471TriethylamineHCID 58080224(R)-4-(4-((4'-chlorobiphenyl-2-yl)(hydroxy)methyl)piperidin-1-yl)benzoic acid2 回HCID 66723800(R)-di-tert-butyl 2-(ethyl(4-(phenylthio)-3-(4-sulfamoyl-2-(trifluoromethylsulfonyl)phenylamino)butyl)amino)ethyl phosphate2 回

生成物 1

HCID 87125282Di-tert-butyl 2-(((R)-3-(4-(N-(4-(4-((R)-(4'-chlorobiphenyl-2-yl)(hydroxy)methyl)piperidin-1-yl)benzoyl)sulfamoyl)-2-(trifluoromethylsulfonyl)phenylamino)-4-(phenylthio)butyl)(ethyl)amino)ethyl phosphate収率 59.5%

試薬・触媒・溶媒 2

HCID 142844-(Dimethylamino)pyridine触媒HCID 6344Dichloromethane溶媒2 回

実験手順

To a solution of (R)-4-(4-((4′-chlorobiphenyl-2-yl)(hydroxy)methyl)piperidin-1-yl)benzoic acid (INTERMEDIATE 40, 88 mg, 0.20 mmol), EDC (77 mg, 0.40 mmol), and DMAP (49 mg, 0.40 mmol), triethylamine (28 μl, 0.20 mmol) in 5 ml of DCM was added (R)-di-tert-butyl 2-(ethyl(4-(phenylthio)-3-(4-sulfamoyl-2-(trifluoromethylsulfonyl)phenylamino)butyl)amino)ethyl phosphate (INTERMEDIATE 50, 150 mg, 0.20 mmol). The mixture was stirred at r.t overnight. The reaction solution was diluted with DCM (20 ml) and washed with water (30 ml). The aqueous layer was extracted with DCM (30 ml) and the combined organic layers were dried over sodium sulfate, and concentrated in vacuo to an oil. This material was purified by column chromatography (ISCO, 0→100% EtOAc/hexane followed by 0→10% MeOH/EtOAc) to provide the title compound (137 mg, yield: 59%).

後処理

  1. washwashed with water (30 ml)
  2. extractionThe aqueous layer was extracted with DCM (30 ml)
  3. dry with materialthe combined organic layers were dried over sodium sulfate
  4. concentrationconcentrated in vacuo to an oil
  5. customThis material was purified by column chromatography (ISCO, 0→100% EtOAc/hexane followed by 0→10% MeOH/EtOAc)

出典と根拠

ORDレコード
ord-247a7b85eaed47ec9b3286bc7a2c02c5
出典データセット
uspto-grants-2016_02
特許番号
US09248140B2

反応ノート

読み込み中…